Legend Biotech Corp (LEGN)

17.5 USD-5.61%close 2026-11-13Healthcare
Gurus hold—none of the tracked superinvestors
Net buying (quarter)—latest quarter, superinvestors
Market Cap$3.24B52 Week Range: 16.65 – 36.28
P/E (TTM)Price/Earnings: share price over annual profit — what you pay per $1 of earnings. Compare within the sector.LossEPS -1.62
The live quote provider is unreachable; the last known close is shown.

Legend Biotech Corp (LEGN) is not among the 30 most-held stocks of the tracked superinvestor set. Price 17.50 USD; market cap $3.24B.

Price & valuation

Prev Close18.54
Open—
Day Range—
52 Week Range16.65 – 36.28
Volume—
Avg Volume (3M)—
BetaVolatility vs the market. Above 1: swings harder than the index.0.552 years, weekly, vs SPY
P/E (TTM)Price/Earnings: share price over annual profit — what you pay per $1 of earnings. Compare within the sector.LossSEC 20-F, 12/31/2025 · per ADS (2 shares)
EPS (TTM)Annual net profit per share.-1.62SEC 20-F, 12/31/2025 · per ADS (2 shares)
Dividend YieldAnnual dividend over share price.—

Pro Feature

This section is exclusive to Fundocap Pro. Full holdings tables, consensus trades, ownership analysis, backtests and exports unlock with Pro.

Upgrade to Pro

About

SectorHealthcare
Industry—
Employees—
Website—

Frequently Asked Questions

Which superinvestors own LEGN?

Legend Biotech Corp (LEGN) is not among the 30 most-held stocks of the tracked superinvestor set.

Is institutional sentiment on LEGN bullish or bearish?

LEGN is not among the 30 most-held stocks of the superinvestor set, so net buyer/seller counts are not computed for it.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.